---
title: "Charles River Laboratories International Inc. Stock Underperforms Monday When Compared To Competitors Despite Daily Gains"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/278449243.md"
description: "Charles River Laboratories International Inc. (CRL) saw its stock rise 1.45% to $176.99 on Monday, despite underperforming compared to competitors like Labcorp Holdings Inc. and Alnylam Pharmaceuticals Inc. The S&P 500 Index increased by 0.83%, while CRL remains 22.67% below its 52-week high of $228.88. Trading volume reached 1.0 million, surpassing its 50-day average of 939,356 shares."
datetime: "2026-03-09T21:17:40.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/278449243.md)
  - [en](https://longbridge.com/en/news/278449243.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/278449243.md)
---

# Charles River Laboratories International Inc. Stock Underperforms Monday When Compared To Competitors Despite Daily Gains

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Charles River Laboratories International Inc. (CRL) rallied 1.45% to $176.99 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 0.83% to 6,795.99 and the Dow Jones Industrial Average rising 0.50% to 47,740.80.

Charles River Laboratories International Inc. closed 22.67% short of its 52-week high of $228.88, which the company reached on January 13th.

The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Labcorp Holdings Inc. (LH) rose 1.46% to $273.61, Alnylam Pharmaceuticals Inc. (ALNY) rose 0.91% to $323.59, and Bio-Techne Corp. (TECH) rose 1.82% to $54.87.

Trading volume (1.0 M) eclipsed its 50-day average volume of 939,356.

Data source: Dow Jones Market Data, FactSet. Data compiled March 9, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

03-09-26 1717ET

### Related Stocks

- [ALNY.US](https://longbridge.com/en/quote/ALNY.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [LH.US](https://longbridge.com/en/quote/LH.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [CRL.US](https://longbridge.com/en/quote/CRL.US.md)
- [TBXU.US](https://longbridge.com/en/quote/TBXU.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [IDNA.US](https://longbridge.com/en/quote/IDNA.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)

## Related News & Research

- [Labcorp Declares Quarterly Dividend | LH Stock News](https://longbridge.com/en/news/282178980.md)
- [Did New Vutrisiran Data and FCF Breakeven Just Shift Alnylam Pharmaceuticals' (ALNY) Investment Narrative?](https://longbridge.com/en/news/282750322.md)
- [Charles River backs AHA to bridge cardiovascular health divide](https://longbridge.com/en/news/282373178.md)
- [Labcorp Holdings Inc. (NYSE:LH) Plans Quarterly Dividend of $0.72](https://longbridge.com/en/news/282250116.md)
- [FDA Rejection Sparks Questions On Replimune Drug Approval Path](https://longbridge.com/en/news/282577359.md)